References
- Bhujwalla Z. M., Tozer G. M., Field S. B., Maxwell R. J., Griffiths J. R. the energy metabolism of RIF-1 tumours following hydralazine. Radiotherapy and Oncology 1990; 19: 281–289
- Burnley I. A., Maxwell R. J., Griffiths J. R., Field S. B. The potential for prazos in and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours. British Journal of Cancer 1991; 64: 683–688
- Evelhoch J. L. Measurement of tumor blood flow by deuterium NMR and the effects of modifiers. NMR Biomed 1992; 5: 290–295
- Falk P. Differences in vascular pattern between the spontaneous and the transplanted C3H mouse mammary carcinoma. European Journal of Cancer and Clinical Oncology 1982; 18: 155–165
- Field S. B., Burney I. A., Needham S., Maxwell R. J., Coggle J., Griffiths J. R. Differences in vascular response between primary and transplanted tumours. British Journal of Cancer 1991; 63: 723–726
- Jain R. K. Determinants of tumour blood flow. A review. Cancer Research, 48: 2461–2658
- Kalmus J., Okunieff P., Vaupel P. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumours. Cancer Research 1990; 50: 15–19
- Lundberg J. M., Franco-Cereceda A., Hua Y., Hokfelt T., Fischer J. A. Coexistence of substance P and calcitonin-gene related peptide like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. European Journal of Pharmacology 1985; 108: 315–319
- McEwan J., Legon S., Wima Tawansa S., Zaidi M., Dollery C., MacIntyre I. Calcitonin gene-related peptide: a review of its biology and relevance to the cardiovascular system. Endocrine Mechanisms in Hypertension, J. H. Laragh, B. N. Brenner, N. M. Kaplan. Raven, New York 1989; 287–306
- Okunieff P., Walsh C. S., Vaupel P., Kallinowski F., Hitzig B. M., Nevringer C. J., Suit H. D. Effects of hydralazine on in vivotumour energy metabolism, haematopoietic radiation sensitivity and cardiovascular parameters. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1145–1148
- Rowell N. P., Flower M. A., McCready V. R., Cronin B., Horwich A. The effects of single dose oral hydralazine on blood flow through human lung tumour. Radiotherapy and Oncology 1990; 18: 283–292
- Tozer G. M., Maxwell R. J., Griffiths J. R., Pham P. Modification of the 32P magnetic resonance spectra of a rat tumour usiing vasodilators and its relation to hypotension. British Journal of Cancer 1990; 62: 553–560